Ligand validation:6HFY

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6HFY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HFY_NAG_C_501	72%	22%	0.114	0.939	1.15	2.22	2	5	0	0	100%	0.9333
6HFY_NAG_D_501	70%	22%	0.12	0.939	1.33	2.04	2	6	0	0	100%	0.9333
6HFY_NAG_A_501	43%	30%	0.177	0.902	1.38	1.52	1	3	0	0	100%	0.9333
6HFY_NAG_C_502	25%	29%	0.236	0.873	1.11	1.86	1	4	0	0	100%	0.9333
6HFY_NAG_B_501	2%	33%	0.425	0.709	0.96	1.8	-	4	0	0	100%	0.9333
6HG5_NAG_A_501	64%	34%	0.11	0.909	1.29	1.44	1	2	0	0	100%	0.9333
1V0Z_NAG_C_506	62%	54%	0.127	0.933	0.67	1.11	-	1	5	0	93%	0.9333
5HUM_NAG_A_503	61%	61%	0.109	0.898	0.8	0.66	1	-	0	0	100%	0.9333
1W1X_NAG_A_1485	55%	66%	0.137	0.905	0.27	1.01	-	1	2	0	100%	0.9333
2CML_NAG_B_2480	51%	8%	0.164	0.918	2.31	2.53	1	6	5	1	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.